(NASDAQ: IVA) Inventiva Sa's forecast annual revenue growth rate of 97.31% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 118.19%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23.42%.
Inventiva Sa's revenue in 2026 is $20,466,279.On average, 8 Wall Street analysts forecast IVA's revenue for 2026 to be $209,500,636, with the lowest IVA revenue forecast at $0, and the highest IVA revenue forecast at $1,004,455,106. On average, 8 Wall Street analysts forecast IVA's revenue for 2027 to be $2,434,512,189, with the lowest IVA revenue forecast at $0, and the highest IVA revenue forecast at $9,040,095,950.
In 2028, IVA is forecast to generate $17,410,555,162 in revenue, with the lowest revenue forecast at $3,066,936,255 and the highest revenue forecast at $37,430,780,350.